Beamtree Holdings Limited (BMT.AX)
AUD 0.21
(-2.44%)
AUD 0.21
(-2.44%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -331 Thousand AUD | 73.31% |
| 2023 | -1.24 Million AUD | 8.86% |
| 2022 | -2.28 Million AUD | -599.88% |
| 2021 | 1.01 Million AUD | -33.25% |
| 2020 | 697.1 Thousand AUD | 236.74% |
| 2019 | -744.49 Thousand AUD | -124.39% |
| 2018 | 2.1 Million AUD | 140.51% |
| 2017 | 1.31 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -822 Thousand AUD | 0.0% |
| 2024 FY | - AUD | 70.0% |
| 2024 Q1 | -1.5 Million AUD | -276.55% |
| 2024 Q2 | -949 Thousand AUD | 52.63% |
| 2024 Q3 | -822 Thousand AUD | -14.97% |
| 2023 Q1 | -1.57 Million AUD | 54.73% |
| 2023 FY | - AUD | 8.86% |
| 2023 Q4 | 265 Thousand AUD | 126.66% |
| 2023 Q3 | -994 Thousand AUD | 52.58% |
| 2023 Q2 | -2.09 Million AUD | -33.12% |
| 2022 Q2 | -1.34 Million AUD | -7.05% |
| 2022 Q1 | -1.26 Million AUD | -299.88% |
| 2022 FY | - AUD | -599.88% |
| 2022 Q4 | -3.47 Million AUD | -58.73% |
| 2022 Q3 | -2.19 Million AUD | -62.38% |
| 2021 Q1 | 18.51 Thousand AUD | -98.48% |
| 2021 Q2 | 109.41 Thousand AUD | 490.86% |
| 2021 Q3 | -222.01 Thousand AUD | -302.92% |
| 2021 Q4 | 630.64 Thousand AUD | 384.05% |
| 2021 FY | - AUD | -33.25% |
| 2020 FY | - AUD | 236.74% |
| 2020 Q4 | 1.21 Million AUD | 1894.23% |
| 2020 Q3 | -67.79 Thousand AUD | -111.87% |
| 2020 Q2 | 571.11 Thousand AUD | 227.33% |
| 2020 Q1 | 174.47 Thousand AUD | 127.27% |
| 2019 Q1 | -26.64 Thousand AUD | -105.31% |
| 2019 FY | - AUD | -124.39% |
| 2019 Q3 | -320.71 Thousand AUD | -1103.51% |
| 2019 Q2 | -26.64 Thousand AUD | 0.0% |
| 2019 Q4 | -639.7 Thousand AUD | -99.46% |
| 2018 Q4 | 502 Thousand AUD | 0.0% |
| 2018 Q1 | 550.5 Thousand AUD | 0.0% |
| 2018 Q2 | 550.5 Thousand AUD | 0.0% |
| 2018 Q3 | 502 Thousand AUD | -8.81% |
| 2018 FY | - AUD | 140.51% |
| 2017 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alcidion Group Limited | -4.49 Million AUD | 92.638% |
| Artrya Limited | -13.95 Million AUD | 97.628% |
| Cogstate Limited | 9.89 Million AUD | 103.346% |
| Careteq Limited | -826.61 Thousand AUD | 59.957% |
| Doctor Care Anywhere Group PLC | -8.35 Million AUD | 96.038% |
| Emyria Limited | -13.03 Million AUD | 97.461% |
| Global Health Limited | -1.76 Million AUD | 81.255% |
| HITIQ Limited | -2.54 Million AUD | 86.982% |
| Intelicare Holdings Limited | -3.02 Million AUD | 89.042% |
| ImExHS Limited | -1.25 Million AUD | 73.683% |
| Mach7 Technologies Limited | -2.44 Million AUD | 86.446% |
| MedAdvisor Limited | 7.04 Million AUD | 104.696% |
| Oakridge International Limited | -630.05 Thousand AUD | 47.465% |
| Opyl Limited | -3.2 Million AUD | 89.686% |
| PainChek Limited | -9.48 Million AUD | 96.512% |
| Pro Medicus Limited | 120.76 Million AUD | 100.274% |
| Resonance Health Limited | -457 Thousand AUD | 27.572% |
| Singular Health Group Ltd | -2.88 Million AUD | 88.527% |
| Total Brain Limited | -5.49 Million AUD | 93.972% |